Embecta Corp. (NASDAQ:EMBC) Position Trimmed by WINTON GROUP Ltd

WINTON GROUP Ltd trimmed its stake in Embecta Corp. (NASDAQ:EMBC) by 6.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 69,141 shares of the company’s stock after selling 4,956 shares during the quarter. WINTON GROUP Ltd owned 0.12% of Embecta worth $1,428,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Smartleaf Asset Management LLC lifted its position in Embecta by 175.1% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,216 shares of the company’s stock worth $25,000 after buying an additional 774 shares in the last quarter. Quarry LP acquired a new position in shares of Embecta in the third quarter worth $30,000. Oppenheimer Asset Management Inc. purchased a new stake in shares of Embecta during the fourth quarter worth $209,000. KLP Kapitalforvaltning AS acquired a new stake in Embecta during the fourth quarter valued at $215,000. Finally, Intech Investment Management LLC purchased a new position in Embecta in the third quarter valued at about $211,000. 93.83% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Embecta

In other news, Director Milton Mayo Morris sold 3,100 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $16.38, for a total value of $50,778.00. Following the sale, the director now directly owns 36,133 shares in the company, valued at approximately $591,858.54. This represents a 7.90 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.42% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Morgan Stanley raised Embecta from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $13.00 to $20.00 in a research note on Monday, December 2nd.

Embecta Stock Down 0.7 %

Shares of EMBC opened at $12.43 on Friday. The firm has a market cap of $722.61 million, a price-to-earnings ratio of 12.43, a price-to-earnings-growth ratio of 0.78 and a beta of 1.27. The company’s fifty day moving average is $15.39 and its 200-day moving average is $16.28. Embecta Corp. has a 12 month low of $9.93 and a 12 month high of $21.48.

Embecta (NASDAQ:EMBC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.20. Embecta had a net margin of 5.25% and a negative return on equity of 19.22%. As a group, research analysts predict that Embecta Corp. will post 2.85 earnings per share for the current fiscal year.

Embecta Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 4.83%. The ex-dividend date was Friday, February 28th. Embecta’s payout ratio is currently 60.00%.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.